130 related articles for article (PubMed ID: 10190298)
21. WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes.
Schittenhelm J; Mittelbronn M; Nguyen TD; Meyermann R; Beschorner R
Brain Pathol; 2008 Jul; 18(3):344-53. PubMed ID: 18371184
[TBL] [Abstract][Full Text] [Related]
22. Ganglioside composition and its relation to clinical data in brain tumors.
Shinoura N; Dohi T; Kondo T; Yoshioka M; Takakura K; Oshima M
Neurosurgery; 1992 Sep; 31(3):541-9. PubMed ID: 1407435
[TBL] [Abstract][Full Text] [Related]
23. Detection of medulloblastoma and astrocytoma-associated ganglioside GD3 in cerebrospinal fluid.
Ladisch S; Chang F; Li R; Cogen P; Johnson D
Cancer Lett; 1997 Nov; 120(1):71-8. PubMed ID: 9570388
[TBL] [Abstract][Full Text] [Related]
24. Expression of gangliosides GD3 and 3'-isoLM1 in autopsy brains from patients with malignant tumors.
Fredman P; von Holst H; Collins VP; Dellheden B; Svennerholm L
J Neurochem; 1993 Jan; 60(1):99-105. PubMed ID: 8417168
[TBL] [Abstract][Full Text] [Related]
25. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
[TBL] [Abstract][Full Text] [Related]
26. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
27. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
28. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
[TBL] [Abstract][Full Text] [Related]
29. Human malignant astrocytes express macrophage phenotype.
Leenstra S; Das PK; Troost D; de Boer OJ; Bosch DA
J Neuroimmunol; 1995 Jan; 56(1):17-25. PubMed ID: 7822478
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.
Aldape KD; Ballman K; Furth A; Buckner JC; Giannini C; Burger PC; Scheithauer BW; Jenkins RB; James CD
J Neuropathol Exp Neurol; 2004 Jul; 63(7):700-7. PubMed ID: 15290895
[TBL] [Abstract][Full Text] [Related]
31. Vascular and perivascular GD3 expression in human glioma.
Koochekpour S; Pilkington GJ
Cancer Lett; 1996 Jun; 104(1):97-102. PubMed ID: 8640753
[TBL] [Abstract][Full Text] [Related]
32. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
33. Membrane lipids modifications in human gliomas of different degree of malignancy.
Campanella R
J Neurosurg Sci; 1992; 36(1):11-25. PubMed ID: 1323645
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical localization of GD3 ganglioside to astrocytes in murine cerebellar mutants.
LeVine SM; Seyfried TN; Yu RK; Goldman JE
Brain Res; 1986 May; 374(2):260-9. PubMed ID: 2424561
[TBL] [Abstract][Full Text] [Related]
35. Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.
Ohkawa Y; Momota H; Kato A; Hashimoto N; Tsuda Y; Kotani N; Honke K; Suzumura A; Furukawa K; Ohmi Y; Natsume A; Wakabayashi T; Furukawa K
J Biol Chem; 2015 Jun; 290(26):16043-58. PubMed ID: 25940087
[TBL] [Abstract][Full Text] [Related]
36. Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity.
Yeh SC; Wang PY; Lou YW; Khoo KH; Hsiao M; Hsu TL; Wong CH
Proc Natl Acad Sci U S A; 2016 May; 113(20):5592-7. PubMed ID: 27143722
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas.
Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Saito T; Matsuura S; Yamasaki F; Arita K; Kurisu K
J Neurooncol; 2006 May; 77(3):273-7. PubMed ID: 16614947
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.
Nduom EK; Yang C; Merrill MJ; Zhuang Z; Lonser RR
J Neurosurg; 2013 Aug; 119(2):427-33. PubMed ID: 23621605
[TBL] [Abstract][Full Text] [Related]
39. Altered 9-O acetylation of disialogangliosides in cerebellar Purkinje cells of the nervous mutant mouse.
Yamamoto M; Schwarting GA; Crandall JE
Brain Res; 1994 Oct; 662(1-2):223-32. PubMed ID: 7859075
[TBL] [Abstract][Full Text] [Related]
40. Ganglioside Composition Distinguishes Anaplastic Ganglioglioma Tumor Tissue from Peritumoral Brain Tissue: Complementary Mass Spectrometry and Thin-Layer Chromatography Evidence.
Fabris D; Karmelić I; Muharemović H; Sajko T; Jurilj M; Potočki S; Novak R; Vukelić Ž
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
